Matches in Nanopublications for { ?s ?p ""Quinapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Quinapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer quinapril tablets are within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS PRECAUTIONS Do not co-administer quinapril tablets with aliskiren in patients with diabetes"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""Quinapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Quinapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer quinapril tablets are within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS PRECAUTIONS Do not co-administer quinapril tablets with aliskiren in patients with diabetes"" assertion.